Table 1.
Patient Characteristics at Enrollment (n = 30)
| Characteristic | n (%/Range) | |
|---|---|---|
| Age | Median (Range) | 61 (35–79) |
|
| ||
| Sex | Male | 17 (57) |
| Female | 13 (43) | |
|
| ||
| FLIPI 1 | Low | 13 (43) |
| Intermediate | 7 (23) | |
| High | 10 (33) | |
|
| ||
| FLIPI 2 | Low | 7 (34) |
| Intermediate | 15 (50) | |
| High | 8 (27) | |
|
| ||
| Prior Therapies | Median (Range) number of treatment regimens | 1 (1–4) |
| Median (Range) time (months) from last therapy | 23.8 (9.8–76.1) | |
| Chemotherapy combination | 21 (70) | |
| Biologic therapy combination | 11 (37) | |
| Radioimmunotherapy | 2 (7) | |
| Rituximab maintenance | 7 (23) | |
| Rituximab monotherapy | 1 (3) | |
| Any Rituximab | 30 (100) | |
| Median (Range) number of prior rituximab doses | 7 (2–22) | |